Systematic Assessment of the Hemolysis Index: Pros and Cons

Advances in Clinical Chemistry

Volumn 71, Issue , 2015, Pages 157-170

  Lippi, Giuseppe ^a  

^a UO Diagnostica Ematochimica   (Italy)

Author keywords

Harmonization; Hemolysis; Hemolysis index; Preanalytical variability; Standardization

Indexed keywords

BLOOD ANALYSIS; BLOOD EXAMINATION; BLOOD SAMPLING; DEVICES; ECONOMICS; HEMOLYSIS; HUMAN; LABORATORY; QUALITY CONTROL; STANDARDS;

BLOOD CHEMICAL ANALYSIS; BLOOD SPECIMEN COLLECTION; HEMATOLOGIC TESTS; HEMOLYSIS; HUMANS; LABORATORIES; QUALITY CONTROL;

EID: 84945457358     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.acc.2015.05.002     Document Type: Chapter

References (46)

1. Lippi G., Banfi G., Church S., Cornes M., De Carli G., Grankvist K., European Federation for Clinical Chemistry and Laboratory Medicine Working Group for Preanalytical Phase, et al. Preanalytical quality improvement. In pursuit of harmony, on behalf of European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working group for Preanalytical Phase (WG-PRE). Clin. Chem. Lab. Med. 2015, 53:357-370. 10.1515/cclm-2014-1051.
2. Simundic A.M. Preanalytical phase-an updated review of the current evidence. Biochem. Med. 2014, 24:6.
3. Simundic A.M., Lippi G. Preanalytical phase-a continuous challenge for laboratory professionals. Biochem. Med. 2012, 22:145-149.
4. Lippi G., Plebani M., Di Somma S., Cervellin G. Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories. Crit. Rev. Clin. Lab. Sci. 2011, 48:143-153.
5. Plebani M. The detection and prevention of errors in laboratory medicine. Ann. Clin. Biochem. 2010, 47(Pt. 2):101-110.
6. Lippi G., Cervellin G., Favaloro E.J., Plebani M. In vitro and in vivo hemolysis. An Unresolved Dispute in Laboratory Medicine 2012, De Gruyter, Berlin, Germany. http://www.degruyter.com/view/product/63034.
7. Lippi G., Pavesi F., Benegiamo A., Pipitone S. What do hemolyzed whole-blood specimens look like? Analysis with a CellaVision DM96 automated image analysis system. J. Lab. Autom. 2015, 20:60-63.
8. Lippi G., Giavarina D., Gelati M., Salvagno G.L. Reference range of hemolysis index in serum and lithium-heparin plasma measured with two analytical platforms in a population of unselected outpatients. Clin. Chim. Acta 2014, 429:143-146.
9. Carraro P., Servidio G., Plebani M. Hemolyzed specimens: a reason for rejection or a clinical challenge?. Clin. Chem. 2000, 46:306-307.
10. Pretlow L., Johnson S., Russell B., Evans B. A novel approach to managing hemolyzed specimens. Clin. Lab. Sci. 2013, 26:153-157.
11. Lippi G., Blanckaert N., Bonini P., Green S., Kitchen S., Palicka V., et al. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin. Chem. Lab. Med. 2008, 46:764-772.
12. Perich C., Minchinela J., Ricós C., Fernández-Calle P., Alvarez V., Doménech M.V., et al. Biological variation database: structure and criteria used for generation and update. Clin. Chem. Lab. Med. 2015, 53:299-305.
13. Fraser C.G. Reference change values. Clin. Chem. Lab. Med. 2011, 50:807-812.
14. Sonntag O., Glick M.R. Serum-Index und Interferogramm-Ein neuer Weg zur Prüfung und Darstellung von Interferenzen durch Serumchromogene. Lab. Med. 1989, 13:77-81.
15. Glick M.R., Ryder K.W., Glick S.J., Woods J.R. Unreliable visual estimation of the incidence and amount of turbidity, hemolysis, and icterus in serum from hospitalized patients. Clin. Chem. 1989, 35:837-839.
16. Hawkins R. Discrepancy between visual and spectrophotometric assessment of sample haemolysis. Ann. Clin. Biochem. 2002, 39:521-522.
17. Simundic A.M., Nikolac N., Ivankovic V., Ferenec-Ruzic D., Magdic B., Kvaternik M., et al. Comparison of visual vs. automated detection of lipemic, icteric and hemolyzed specimens: can we rely on a human eye?. Clin. Chem. Lab. Med. 2009, 47:1361-1365.
18. Zwart A., van Assendelft O.W., Bull B.S., England J.M., Lewis S.M., Zijlstra W.G. Recommendations for reference method for haemoglobinometry in human blood (ICSH standard 1995) and specifications for international haemiglobinocyanide standard (4th edition). J. Clin. Pathol. 1996, 49:271-274.
19. Hall A.H., Saiers J., Baud F. Which cyanide antidote?. Crit. Rev. Toxicol. 2009, 39:541-552.
20. Clinical and Laboratory Standard Institute Hemolysis, Icterus, and Lipemia/Turbidity Indices as Indicators of Interference in Clinical Laboratory Analysis; Approved Guideline C56-A 2012, Clinical and Laboratory Standards Institute, Wayne, PA.
21. Dolci A., Panteghini M. Harmonization of automated hemolysis index assessment and use: is it possible?. Clin. Chim. Acta 2014, 432:38-43.
22. Lippi G., Banfi G., Buttarello M., Ceriotti F., Daves M., Dolci A., et al. Recommendations for detection and management of unsuitable samples in clinical laboratories. Clin. Chem. Lab. Med. 2007, 45:728-736.
23. Simundic A.M., Topic E., Nikolac N., Lippi G. Hemolysis detection and management of hemolysed specimens. Biochem. Med. 2010, 20:154-159.
24. Lippi G., Luca Salvagno G., Blanckaert N., Giavarina D., Green S., Kitchen S., et al. Multicenter evaluation of the hemolysis index in automated clinical chemistry systems. Clin. Chem. Lab. Med. 2009, 47:934-939.
25. Lippi G., Avanzini P., Campioli D., Da Rin G., Dipalo M., Aloe R., et al. Systematical assessment of serum indices does not impair efficiency of clinical chemistry testing: a multicenter study. Clin. Biochem. 2013, 46:1281-1284.
26. Petrova D.T., Cocisiu G.A., Eberle C., Rhode K.H., Brandhorst G., Walson P.D., et al. Can the Roche hemolysis index be used for automated determination of cell-free hemoglobin? A comparison to photometric assays. Clin. Biochem. 2013, 46:1298-1301.
27. Plebani M., Lippi G. Hemolysis index: quality indicator or criterion for sample rejection?. Clin. Chem. Lab. Med. 2009, 47:899-902.
28. Plebani M., Astion M.L., Barth J.H., Chen W., de Oliveira Galoro C.A., Escuer M.I., et al. Harmonization of quality indicators in laboratory medicine. A preliminary consensus. Clin. Chem. Lab. Med. 2014, 52:951-958.
29. Fernandez P., Llopis M.A., Perich C., Alsina M.J., Alvarez V., Biosca C., et al. Harmonization in hemolysis detection and prevention. A working group of the Catalonian Health Institute (ICS) experience. Clin. Chem. Lab. Med. 2014, 52:1557-1568.
30. Lippi G., Avanzini P., Dipalo M., Aloe R., Cervellin G. Influence of hemolysis on troponin testing: studies on Beckman Coulter UniCel Dxl 800 Accu-TnI and overview of the literature. Clin. Chem. Lab. Med. 2011, 49:2097-2100.
31. Wenk R.E. Mechanism of interference by hemolysis in immunoassays and requirements for sample quality. Clin. Chem. 1998, 44:2554.
32. Snyder J.A., Rogers M.W., King M.S., Phillips J.C., Chapman J.F., Hammett-Stabler C.A. The impact of hemolysis on ortho-clinical diagnostic's ECi and Roche's elecsys immunoassay systems. Clin. Chim. Acta 2004, 348:181-187.
33. Garinet S., Fellahi S., Marlin G., Capeau J., Lefèvre G., Bastard J.P. Differential interferences of hemoglobin and hemolysis on insulin assay with the Abbott Architect-Ci8200 immunoassay. Clin. Biochem. 2014, 47:445-447.
34. Lippi G., Avanzini P., Zobbi V., Ippolito L. Influence of mechanical hemolysis of blood on two D-dimer immunoassays. Blood Coagul. Fibrinolysis 2012, 23:461-463.
35. Rodríguez-Granger J., Camacho-Muñoz E., Sampedro A., Rosa-Fraile M. Interference of hemolysis in serological immunoassays. Enferm. Infecc. Microbiol. Clin. 2006, 24:534-535.
36. Nikolac N., Simundic A.M., Miksa M., Lima-Oliveira G., Salvagno G.L., Caruso B., et al. Heterogeneity of manufacturers' declarations for lipemia interference-an urgent call for standardization. Clin. Chim. Acta 2013, 426:33-40.
37. Blumenthal D., Stremikis K., Cutler D. Health care spending-a giant slain or sleeping?. N. Engl. J. Med. 2013, 369:2551-2557.
38. Sciacovelli L., Zardo L., Secchiero S., Plebani M. Quality specifications in EQA schemes: from theory to practice. Clin. Chim. Acta 2004, 346:87-97.
39. Adams O., Cooper G., Fraser C., Hubmann M., Jones G., Plebani M., et al. Collective opinion paper on findings of the 2011 convocation of experts on laboratory quality. Clin. Chem. Lab. Med. 2012, 50:1547-1558.
40. Büttner J., Borth R., Broughton P.M., Bowyer R.C. Approved recommendation (1983) on quality control in clinical chemistry. Part 4. Internal quality control. J. Clin. Chem. Clin. Biochem. 1983, 21:877-884.
41. Lippi G., Plebani M. Continuous-flow automation and hemolysis index: a crucial combination. J. Lab. Autom. 2013, 18:184-188.
42. Szybowska P., Mamica K., Berska J., Sztefko K. Reporting of hemolysis index (HI) with laboratory results should be obligatory in newborns and infants. Clin. Chem. Lab. Med. 2015, 53:e147-e149.
43. Gillery P., Young I.S., IFCC Scientific Division Progress towards standardization: an IFCC Scientific Division Perspective. Clin. Chem. Lab. Med. 2013, 51:915-918.
44. Zini G., Kern W., Brereton M., Stephens A.D. ICSH: on board for new projects. Int. J. Lab. Hematol. 2014, 36:306-312.
45. Oosterhuis W., Kleinveld H., Mücke M. Detection of a monoclonal gammopathy by serum index measurement. Clin. Chem. Lab. Med. 2009, 47:614-615.
46. Drieghe S., Stove V., Decruyenaere J., Delanghe J. Interpretation of hemolysis tests following administration of a second-generation hemoglobin-based oxygen carrier. Acta Clin. Belg. 2013, 68:282-286.